Status:
TERMINATED
Prospective Evaluation Among Patients Infected by HIV 1 in Virological Failure Owing to Lack of Compliance, of the Benefit in Terms of Compliance of an Optimised Antiretroviral Treatment With Enfuvirtide (Fuzeon) Associated With Two Active Molecules
Lead Sponsor:
University Hospital, Rouen
Collaborating Sponsors:
Hoffmann-La Roche
Conditions:
HIV1 Infection
HIV Infections
Eligibility:
All Genders
18+ years
Brief Summary
In case of lack of compliance in HIV1 patients, the investigators hope to prove that enfuvirtide injection during almost 3 months, with nurse help at home and therapeutic education may contribute to o...
Eligibility Criteria
Inclusion
- virological failure, more than 18 years, prouved lack of compliance, with no sub-optimal treatment, in ambulatory status.
Exclusion
- hospitalization,HIV2 infection,pregnancy,preliminary treatment with enfuvirtide,chimiotherapy , opportunistic infection in progress
Key Trial Info
Start Date :
June 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2011
Estimated Enrollment :
4 Patients enrolled
Trial Details
Trial ID
NCT00937729
Start Date
June 1 2009
End Date
December 1 2011
Last Update
February 16 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Borsa-Lebas
Rouen, France, 76031